IQVIA Holdings | IQV - Le Bénéfice D'Exploitation





Le Bénéfice D'Exploitation Changement Date
Accenture USD 3.18B 516.22M 2025-09
Agilent USD 353M 90M 2025-12
Bruker USD 76.3M 7.6M 2025-12
Cardinal Health USD 763M 9M 2025-12
Celltrion KRW 301.04B 58.57B 2025-09
Charles River Laboratories USD 75.82M 57.98M 2025-12
Cigna USD 2.75B 240M 2025-09
Cognizant Technology Solutions USD 853M 13M 2025-12
Computer Programs Systems USD 1.94M 4.96M 2024-09
Cspc Pharmaceutical CNY 1.22B 60.54M 2025-09
CVS Health USD 2.11B 836M 2025-12
Danaher USD 1.5B 348M 2025-12
Dentsply International USD 538M 26M 2025-12
Deva Holding AS TRY 964.87M 240.32M 2023-09
Dianthus Therapeutics USD -40.29M 5.36M 2025-09
Divis Laboratories Ltd INR 7.72B 30M 2025-12
Elevance Health USD 581M 1.18B 2025-12
Hologic USD 237M 16M 2025-12
Humana USD -808M 1.21B 2025-12
IBM USD 4.25B 1.7B 2025-12
Illumina USD 256M 6M 2025-12
Infosys INR 84.09B 83.02B 2025-12
Kangmei Pharma CNY -26.7M 43.13M 2025-09
Knight Therapeutics CAD 2.94M 2.4M 2025-09
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Laboratory Of America USD 382M 15.3M 2025-12
Malin Corporation EUR -1.1M 400K 2024-12
McKesson USD 1.66B 159M 2025-12
Mettler Toledo International USD 351.93M 57.73M 2025-12
Organigram Holdings CAD -28.05M 7.76M 2025-09
Ovoca Bio EUR -5.65M 3.45M 2022-06
Pharma Mar EUR 43.61M 47.57M 2025-12
Publicis EUR 1.2B 144M 2025-06
Qiagen NV USD 121.88M 15.41M 2025-12
Quest Diagnostics USD 386M 0 2025-12
Revvity USD 145.83M 47.49M 2025-12
Sartorius EUR 150.1M 11.7M 2025-09
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Thermo Fisher Scientific USD 2.3B 226M 2025-12
Tilray USD -20.01M 9.34M 2025-09
UnitedHealth USD 3.26B 1.06B 2025-12
Veeva Systems USD 245.88M 5.02M 2025-12
Veradigm USD -45.47M 70.47M 2022-12
Waters USD 270.52M 78.4M 2025-12
Zz Pientze Pharmaceu CNY 501.33M 52.54M 2025-09